ORIGINAL RESEARCH article
Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1610967
This article is part of the Research TopicHunting for Inflammation Mediators: Identifying Novel Biomarkers for Autoimmune and Autoinflammatory DiseasesView all 10 articles
Prognostic value of nine inflammatory biomarkers for critically ill patients with rheumatic heart disease: a retrospective study
Provisionally accepted
Ying Zhang
Xiaofei Ni*- Zhangjiagang City First People's Hospital, Zhangjiagang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Among various inflammatory biomarkers, the prognostic value in critically ill patients with rheumatic heart disease (RHD) remains unclear. This study aimed to compare the prognostic value of different inflammatory biomarkers in patients with RHD.Methods: This study identified critically ill patients admitted to the intensive care unit from the Medical Information Mart for Intensive Care IV database (MIMIC-IV). Nine systemic inflammatory biomarkers, derived from various combinations of neutrophils, lymphocytes, monocytes, and platelets, were evaluated for their association with 30-day all-cause mortality. Receiver operating characteristic curve analysis was performed to identify the most predictive biomarker. Furthermore, Cox proportional hazards regression and restricted cubic spline analysis were employed to evaluate the association between the optimal biomarker and survival outcomes.Results: A total of 1002 patients with RHD were included. Eight inflammatory biomarkers were predictive for 30-day all-cause mortality and the platelet-to-lymphocyte ratio (PLR) demonstrated the highest area under the curve value of 0.794 among these biomarkers. Then patients were divided into tertiles based on PLR. Multivariate Cox proportional hazards analysis demonstrated that an elevated PLR was significantly associated with increased 30-day all-cause mortality. After adjustment for potential confounders, elevated PLR remained an independent predictor of mortality (adjusted hazard ratio: 2.53; 95% confidence interval: 1.87–3.42; p < 0.001). Furthermore, restricted cubic spline analysis revealed a progressively increasing risk of all-cause mortality with higher PLR levels.Conclusion: These findings indicate that the PLR may be a useful indicator for evaluating the severity and guiding the treatment of RDH patients.
Keywords: Critical Care, Inflammatory biomarker, Mortality, platelet-to-lymphocyte ratio, Rheumatic Heart Disease
Received: 13 Apr 2025; Accepted: 12 May 2025.
Copyright: © 2025 Zhang and Ni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiaofei Ni, Zhangjiagang City First People's Hospital, Zhangjiagang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.